1-3 of 3
Erik Ahlstrand, MD
Close
Sort by
Journal Articles

A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

Raija Helena Silvennoinen, MDPhD, Anders Waage, MD PhD, Valdas Peceliunas, MD, Fredrik Schjesvold, MDPhD, Pekka Anttila, MD, Marjaana Säily, MD PhD, Mervi Putkonen, MD PhD, Kristina Carlson, MD, Einar Haukaas, MD, Marja Sankelo, MDPhD, Anu Partanen, MD PhD, Damian L. Szatkowski, MDPhDMSc, Markus Hansson, MD PhD, Anu Marttila, MD, Lucia Ahlberg, MD, Per Axelsson, MD, Birgitta Lauri, MD, Maija Helena Mikkola, MD, Conny Karlsson, MD, Johanna Abelsson, MD, Erik Ahlstrand, MD PhD, Anu Sikiö, MD, Monika Klimkowska, MD PhD, Reda Matuzeviciene, MD PhD, Mona Hoysaeter Fenstad, MD PhD, Sorella Ilveskero, MD PhD, Hareth Nahi, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-138643
Published: 2020
Journal Articles

Highly Reduced Survival in ET and PV Patients with Vascular Complications during Follow-up - Real World Data from the Swedish MPN Registr

Marie Lindgren, Erik Ahlstrand, MD PhD, Helna Pettersson, MD, Maria Liljeholm, Anna Ravn-Landtblom, MD, Stefan Scheding, Prof, Björn Andréasson, MD PhD, Jan Samuelsson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1658.
https://doi.org/10.1182/blood-2019-124374
Published: 2019
Journal Articles

A Phase II Study of Vorinostat (MK-0683) in Patients with Polycythemia Vera and Essential Thrombocythemia

Christen Lykkegaard Andersen, MD, Mary Frances McMullin, MD, Elisabeth Ejerblad, MD, Sonja Zweegman, MD, PhD, Claire N Harrison, DM FRCP FRCPath, Savio Fernandes, MD, David Bareford, MD, Steven Knapper, MD, Jan Samuelsson, MD, Eva Löfvenberg, MD, Olle Linder, MD, Bjørn Andreasson, MD, Erik Ahlstrand, MD, Morten K. Jensen, MD, Ole Weis Bjerrum, MD, Hanne Vestergaard, MD, Herdis Larsen, MD, Tobias Wirenfeldt Klausen, Torben mourits-Andersen, MD, Hans Hasselbalch, MD
Journal: Blood
Blood (2012) 120 (21): 803.
https://doi.org/10.1182/blood.V120.21.803.803
Published: 2012